Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on ETNB: 89bio NewsMORE ...

On October 17, 2024, Suvretta Capital Management, LLC executed a significant transaction involving the shares of 89bio Inc (NASDAQ ... the grant of non-qualified stock options to purchase an ...

Two analysts have rated the stock with a hold recommendation ... On average, sell-side analysts forecast that 89bio will post -2.32 EPS for the current year. 89bio, Inc, a clinical-stage ...

However that may be, 89bio (NASDAQ:ETNB) was not a THR-β stock, so it fell on that news; and again, when resmetirom got its approval in March 2024, the stock fell, and has continued falling.

SAN FRANCISCO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Making long-term predictions for individual stock prices is very difficult. Past performance doesn't guarantee future results. Whether a stock has done well or fared poorly, the tide can shift ...

Expert predictions for stock market growth in 2025 vary from a 5% decline to growth of 20%. Many pundits are pegging a 10% increase as the most likely scenario. Richard McWhorter, managing partner ...

As of the latest data, 89bio Inc holds a market capitalization of approximately $869.517 million, with a current stock price of $8.21. The company's financial performance shows a GF Score of 40/ ...

Amazon stock increased over 40% year over year as of Oct. 28, 2024. But it is not guaranteed to continue rising at this pace. Some predictions of Amazon stock suggest it could reach about $215 per ...

Tesla earnings are due amid Model Y refresh buzz. TSLA stock has tumbled in October on Q3 deliveries and the robotaxi event. BYD stock is back in a buy zone. We recently looked at Goldman Sachs’ ...